Clinical Trials Directory

Trials / Completed

CompletedNCT05752669

Oxidative Stress and Mitochondrial TERT in Papillary Thyroid Cancer.

The Role of Oxidative Stress and Mitochondrial TERT in the Progression and Therapeutic Resistance of Papillary Thyroid Cancer.

Status
Completed
Phase
Study type
Observational
Enrollment
100 (actual)
Sponsor
Istituto Auxologico Italiano · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Oxidative stress (OS) could be involved in the progression of papillary thyroid cancer (PTC). Indeed, thyroid differentiation genes are silenced by a mechanism controlled by NOX4-derived OS. On the other hand, TERT contributes to mitochondrial OS protection, which could increase the resistance of cancer cells to therapeutic agents. The investigators aim to address the role of OS and mitochondrial TERT in the progression and therapeutic resistance of PTC. OS and TERT subcellular localization will be investigated in 150 PTCs and correlated to the genetic and expression profile of the tumors and to the clinical and prognostic features of the patients. Mechanisms implicated in TERT mitochondrial migration and the contribution of mitochondrial TERT to tumor progression will be investigated in cancer cell lines and primary cell cultures. This study will allow to identify OS as a marker of therapeutic resistance in PTC and will open new opportunities for the development of novel treatments targeting ROS generation/TERT nuclear export.

Conditions

Timeline

Start date
2021-09-15
Primary completion
2025-05-31
Completion
2025-05-31
First posted
2023-03-03
Last updated
2025-08-21

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT05752669. Inclusion in this directory is not an endorsement.